Improvement of Hyperglycemia Following Treatment with Erlotinib

Endocrine. 2025 Jan;87(1):348-350. doi: 10.1007/s12020-024-03996-w. Epub 2024 Aug 9.

Authors

Arif Hakan Onder¹, Cihan Heybeli²

Affiliations

¹ Division of Oncology, Antalya Education and Research Hospital, Antalya, Türkiye.
² Division of Nephrology, Dokuz Eylul University Hospital, Izmir, Türkiye. heybelic@hotmail.com.

PMID: 39120844
DOI: 10.1007/s12020-024-03996-w

No abstract available

Keywords: Cancer; Diabetes Mellitus; Erlotinib Hydrochloride; Hyperglycemia.

Publication types

Letter